SCHEMBL331131

SCHEMBL331131

C=C(C)C(=O)OSCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
ELANE P08246 1/20 0.41
CYP2C19 P33261 1/20 0.40
IDO1 P14902 2/20 0.39
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
MAOB P27338 1/20 0.36
GAA P10253 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 1/20 0.36
PTGS2 P35354 1/20 0.36
PKM P14618 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
FFAR1 O14842 1/20 0.35
MAPK1 P28482 1/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
AKR1B1 P15121 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18927197 0.83 IDO1 (0.35) ALDH1A1ELANEIDO1TDP1
SCHEMBL10519643 0.82 ALDH1A1 (0.52) ALDH1A1CYP2C19IDO1KDM4ELMNA
SCHEMBL29283557 0.78 AKR1C3 (0.50) ALDH1A1LMNAMAPTAKR1B1
SCHEMBL5688937 0.77 CYP2C19 (0.47) ALDH1A1CYP2C19IDO1LMNATDP1
SCHEMBL1722106 0.77 CYP2C19 (0.47) ALDH1A1CYP2C19IDO1LMNATDP1
SCHEMBL45252 0.75 RAB9A (0.47) ALDH1A1ELANECYP2C19IDO1LMNA
SCHEMBL7519970 0.74 CYP2C19 (0.50) ALDH1A1CYP2C19IDO1LMNATDP1
SCHEMBL1093413 0.74 L3MBTL1 (0.42) ALDH1A1ELANEKDM4ELMNAL3MBTL1
Acetic Acid SCHEMBL28365922 0.74 ALDH1A1 (0.47) ALDH1A1CYP2C19IDO1KDM4ELMNA
SCHEMBL27847625 0.74 TDP1 (0.55) ALDH1A1CYP2C19IDO1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6022496-A Chromene compound TOKUYAMA CORPORATION (JP) 2000-02-08 US claimed
US-20260110823-A1 OPTICAL ELEMENT, OPTICAL APPARATUS, IMAGING APPARATUS, AND COMPOUND CANON KK (JP) 2026-04-23 US disclosed
US-12529822-B2 Optical element, optical apparatus, imaging apparatus, and compound CANON KABUSHIKI KAISHA (JP) 2026-01-20 US disclosed
EP-3345954-B1 POLYROTAXANE, PRODUCTION METHOD THEREFOR, AND OPTICAL COMPOSITION CONTAINING SAID POLYROTAXANE TOKUYAMA CORP (JP) 2023-07-05 EP disclosed
US-11578174-B2 Polyrotaxane, production method therefor, and optical composition containing said polyrotaxane TOKUYAMA CORPORATION (JP) 2023-02-14 US disclosed
US-20220137261-A1 OPTICAL ELEMENT, OPTICAL APPARATUS, IMAGING APPARATUS, AND COMPOUND CANON KABUSHIKI KAISHA (JP) 2022-05-05 US disclosed
EP-3269774-B1 METHOD FOR PRODUCING PHOTOCHROMIC CURED BODY TOKUYAMA CORP (JP) 2020-12-09 EP disclosed
EP-2497791-B1 METHOD FOR PRODUCING INTERNAL MOLD RELEASE AGENT FOR OPTICAL MATERIAL, INTERNAL MOLD RELEASE AGENT FOR OPTICAL MATERIAL, AND POLYMERIZABLE COMPOSITION INCLUDING THE SAME MITSUI CHEMICALS INC (JP) 2020-05-13 EP disclosed
US-20200071467-A1 Polyrotaxane, Production Method Therefor, and Optical Composition Containing said Polyrotaxane TOKUYAMA CORPORATION (JP) 2020-03-05 US disclosed
CN-105137508-B Compound, optical material and optical element used for optical elements 佳能株式会社 2019-11-08 CN disclosed
US-6141135-A Photochromic composition TOKUYAMA CORPORATION (JP) 2000-10-31 US disclosed
US-6114485-A STARTING MATERIAL FOR A RESIN COMPOSITION USED IN OPTICAL APPLICATIONS SUCH AS A LENS MITSUI CHEMICALS, INC. (JP) 2000-09-05 US disclosed
US-6022496-A Chromene compound TOKUYAMA CORPORATION (JP) 2000-02-08 US disclosed
EP-0965628-A1 Photochromic composition TOKUYAMA CORPORATION (JP) 1999-12-22 EP disclosed
EP-0942027-A2 A polymerizable composition Mitsui Chemicals, Inc. (JP) 1999-09-15 EP disclosed
US-5932725-A PHOTOCHROMIC; E.G., 3,3-BIS(3-FLUORO-4-METHOXYPHENYL)-6-MORPHOLINO-3H-BENZO(F)-CHR OMENE TOKUYAMA CORPORATION (JP) 1999-08-03 US disclosed
US-5916987-A OPTICAL RESIN; LENSES MITSUI CHEMICALS, INC. (JP) 1999-06-29 US disclosed
EP-0875509-A1 Chromene compound TOKUYAMA CORPORATION (JP) 1998-11-04 EP disclosed
CN-1173490-A Thiol and sulfur-containing 0- (meth) acrylate compound and use thereof MITSUI TOATSU CHEMICALS (JP) 1998-02-18 CN disclosed
EP-0810210-A2 Thiol and sulfur-containing o-(meth)acrylate compounds and use thereof MITSUI TOATSU CHEMICALS, INC. (JP) 1997-12-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260110823-A1 OPTICAL ELEMENT, OPTICAL APPARATUS, IMAGING APPARATUS, AND COMPOUND RAD51, PIEZO1, ZYX ALDH1A1 1504/4885ELANE 1306/4885CYP2C19 2396/4885
US-12529822-B2 Optical element, optical apparatus, imaging apparatus, and compound RAD51, SEM1, PSMA3 ALDH1A1 1261/4885ELANE 699/4885CYP2C19 3379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.